why is retatrutide better than ozempic Retatrutide: The Unapproved Drug America Already Takes I plateaued on Ozempic —

As we move forward, lets explore the landscape of weight loss medications in 2025 and how they fit into UMRs coverage policies

Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

About Mochi Health Mochi Health is a subscription-based telehealth platform

The compound rewards routine and punishes improvisation

August 28, 2025 To evaluate the effect of GLP-1 drugs on food, weight, and health in the US, it is important to look first at the macro context for large-scale mega-trends

For the treatment of T2D, the FDA gave their approval in 2017